Should You Buy Transcat Inc (TRNS) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Hold
Latest Price
60.310
1 Day change
3.09%
52 Week Range
97.080
Analysis Updated At
2026/01/26
Transcat Inc (TRNS) is not a strong buy at this moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company shows revenue growth and plans for market expansion, the significant drop in net income and EPS, along with neutral technical indicators and lack of strong trading signals, suggest waiting for clearer positive catalysts or financial improvements before investing.
Technical Analysis
The technical indicators for TRNS are neutral. The MACD histogram is slightly positive at 0.0337, but contracting. The RSI is at 50.381, indicating no clear overbought or oversold conditions. Moving averages are converging, and the stock is trading near its support level of 62.28. The pivot point is at 64.342, with resistance levels at 66.405 and 67.68.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Technical Summary
Sell
6
Buy
6
Positive Catalysts
The company plans to expand its addressable calibration market through acquisitions and capability investments, which could drive future growth.
Neutral/Negative Catalysts
Net income dropped by 61.38% YoY, and EPS decreased by 60.00% YoY in Q2 2026, indicating profitability challenges. No recent insider or hedge fund activity, and no strong trading signals from Intellectia Proprietary Trading Signals.
Financial Performance
In Q2 2026, revenue increased to $82.27M (up 21.30% YoY), but net income dropped to $1.27M (down 61.38% YoY). EPS decreased to $0.14 (down 60.00% YoY), and gross margin improved slightly to 32.53% (up 4.03% YoY).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No recent analyst rating or price target changes available for TRNS.
Wall Street analysts forecast TRNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TRNS is 100 USD with a low forecast of 95 USD and a high forecast of 105 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast TRNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TRNS is 100 USD with a low forecast of 95 USD and a high forecast of 105 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 58.500
Low
95
Averages
100
High
105
Current: 58.500
Low
95
Averages
100
High
105
Northland
Ted Jackson
Market Perform -> Outperform
upgrade
$85 -> $95
AI Analysis
2025-10-23
Reason
Northland
Ted Jackson
Price Target
$85 -> $95
AI Analysis
2025-10-23
upgrade
Market Perform -> Outperform
Reason
Northland analyst Ted Jackson upgraded Transcat to Outperform from Market Perform with a price target of $95, up from $85. The firm is "comfortable" with the company's ability to meet both Q2 and FY26 expectations and sees a period of improving financial performance driven by recent acquisitions and fading NEXA headwinds, says the analyst, who has raised the firm's EBITDA forecast to now align with consensus.
Lake Street
NULL -> Buy
initiated
$105
2025-07-10
Reason
Lake Street
Price Target
$105
2025-07-10
initiated
NULL -> Buy
Reason
Lake Street initiated coverage of Transcat with a Buy rating and $105 price target. Transcat is a "compelling" way to gain exposure in the calibration and test & measurement market, and the company's ability to execute on its growth strategy through its Service segment and inorganic opportunities should lead to long-term top and bottom line growth, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for TRNS
